S.Suman1, P. Karthikeyan2, S.Moulishankar3, S.Sridhar4, G. Raaja5*, G.S. Aathithiah6, M.Vetriselvan7, Joemon8, R.Pachiyappan9, B. Devendran10
| Authors: 1Managing Director, Vijayani Nutraceuticals Pvt Ltd, 2Director, Vijayani Nutraceuticals Pvt Ltd, 3Director, Vijayani Nutraceuticals Pvt Lt, 4 Principal Research Investigator, Ashram Siddha Research Institute, 5Medical Officer, Vijayani Nutraceuticals Pvt Ltd, 6Medical Officer, Vijayani Nutraceuticals Pvt Ltd, 7General Manager, Vijayani Nutraceuticals Pvt Ltd, 8Manufacturing Incharge, Vijayani Nutraceuticals Pvt Ltd, 9Product Development, Oriens Global Marketing Pvt Ltd, 10 Pharmacologist, Vijayani Nutraceuticals Pvt Ltd Corresponding Author: *Dr. G. Raaja, Medical Officer, Vijayani Nutraceuticals Pvt. Ltd., Chennai, Tamil Nadu, India. Email ID: raaja.ayurdoctor@gmail.com |
Abstract
| Introduction: Obesity and hypercholesterolemia are significant global health concerns, contributing to metabolic disorders such as cardiovascular disease and type 2 diabetes. Conventional treatments often include pharmacological interventions and lifestyle modifications, which may have limitations in terms of adherence and side effects. Ayurvedic medicine offers a holistic approach to weight management and metabolic regulation. DELIPO CAPSULE, a proprietary Ayurvedic formulation, has been developed to address symptoms associated with obesity, including shortness of breath, fatigue, excessive sweating,, difficulty in sleeping and high LDL cholesterol levels. Objective: The primary objective of this study was to evaluate the clinical efficacy of DELIPO CAPSULE in managing symptoms of obesity and hypercholesterolemia. Methods: The study aimed to assess its impact on weight management, cholesterol levels, and associated symptoms over a 30-day treatment period. This Phase-II-A, single-center, open-label, therapeutic exploratory clinical trial was conducted on 20 patients diagnosed with obesity-related conditions. Participants were administered 1-2 DELIPO CAPSULES twice daily with lukewarm water for 30 days. Clinical and laboratory assessments were performed at baseline (day-1) and post-treatment (day-30). Ethical approval was obtained, and written informed consent was secured from all participants. Results: After 30 days of treatment: 75% (15 patients) experienced significant symptom improvement. 15% (3 patients) showed moderate improvement. 5% (1 patient) had mild improvement. 5% (1 patient) dropped out of the study. Laboratory investigations confirmed improvements in cholesterol levels and metabolic markers. Conclusion: DELIPO CAPSULE demonstrated significant efficacy in managing obesity-related symptoms and metabolic imbalances. The findings support its potential as a safe and effective Ayurvedic intervention for weight management and hypercholesterolemia. |
| Keywords: Obesity, Hypercholesterolemia, Metabolic disorders, Ayurvedic medicine |
| Received on 29th January 2025; Revised on 18th February 2025; Accepted on 28th February 2025, DOI:10.36678/IJMAES.2025.V11I01.002 |
Leave a Reply